PNC Financial Services Group
BNTC icon

PNC Financial Services Group’s Benitec Biopharma BNTC Stock Holding History

PNC Financial Services Group’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13K Buy
234
+38
+19% +$451 ﹤0.01% 4547
2026
Q1 		$2.09K Buy
196
+49
+33% +$567 ﹤0.01% 4566
2025
Q4 		$1.98K Buy
147
+142
+2,840% +$1.96K ﹤0.01% 4531
2025
Q3 		$70 Buy
+5
New +$64 ﹤0.01% 5018

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

PNC Financial Services Group's BNTC Position: Q2 2026 in Review

PNC Financial Services Group increased its Benitec Biopharma (BNTC) stake by 19% in Q2 2026, buying an estimated $451 and bringing the position to 234 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4547.

PNC Financial Services Group first reported a position in BNTC in Q3 2025 and has held it in 4 quarters since. 86 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • PNC Financial Services Group held 234 shares of Benitec Biopharma worth $3.13K as of Q2 2026.
  • PNC Financial Services Group bought 38 Benitec Biopharma shares in Q2 2026, an estimated $451.
  • Benitec Biopharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4547 holding.
  • PNC Financial Services Group first reported a position in Benitec Biopharma in Q3 2025 and has held it in 4 quarters since.
  • 86 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.